These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28268233)

  • 1. Does Computed Tomography Still Have Limitations to Distinguish Benign from Malignant Renal Tumors for Radiologists?
    Shin T; Duddalwar VA; Ukimura O; Matsugasumi T; Chen F; Ahmadi N; de Castro Abreu AL; Mimata H; Gill IS
    Urol Int; 2017; 99(2):229-236. PubMed ID: 28268233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
    Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
    Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
    Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
    Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can radiologists and urologists reliably determine renal mass histology using standard preoperative computed tomography imaging?
    Monn MF; Gellhaus PT; Patel AA; Masterson TA; Tann M; Boris RS
    J Endourol; 2015 Apr; 29(4):391-6. PubMed ID: 25222030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
    Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
    Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
    Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
    AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
    Gorin MA; Rowe SP; Baras AS; Solnes LB; Ball MW; Pierorazio PM; Pavlovich CP; Epstein JI; Javadi MS; Allaf ME
    Eur Urol; 2016 Mar; 69(3):413-6. PubMed ID: 26386607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small (< or = 4 cm) cortical renal tumors: characterization with multidetector CT.
    Alshumrani G; O'Malley M; Ghai S; Metser U; Kachura J; Finelli A; Mattar K; Panzarella T
    Abdom Imaging; 2010 Aug; 35(4):488-93. PubMed ID: 19536589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of benign from malignant solid renal lesions using CT-based radiomics and machine learning: comparison with radiologist interpretation.
    Wentland AL; Yamashita R; Kino A; Pandit P; Shen L; Brooke Jeffrey R; Rubin D; Kamaya A
    Abdom Radiol (NY); 2023 Feb; 48(2):642-648. PubMed ID: 36370180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated classification of solid renal masses on contrast-enhanced computed tomography images using convolutional neural network with decision fusion.
    Zabihollahy F; Schieda N; Krishna S; Ukwatta E
    Eur Radiol; 2020 Sep; 30(9):5183-5190. PubMed ID: 32350661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
    Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
    Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can contrast-enhanced ultrasound and acoustic radiation force impulse imaging characterize CT-indeterminate renal masses? A prospective evaluation with histological confirmation.
    Thaiss WM; Bedke J; Kruck S; Spira D; Stenzl A; Nikolaou K; Horger M; Kaufmann S
    World J Urol; 2019 Jul; 37(7):1339-1346. PubMed ID: 30324296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping.
    Varghese BA; Chen F; Hwang DH; Cen SY; Desai B; Gill IS; Duddalwar VA
    AJR Am J Roentgenol; 2018 Dec; 211(6):W288-W296. PubMed ID: 30240299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
    Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
    Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Contour Analysis as an Image-based Discriminator Between Benign and Malignant Renal Tumors.
    Yap FY; Hwang DH; Cen SY; Varghese BA; Desai B; Quinn BD; Gupta MN; Rajarubendra N; Desai MM; Aron M; Liang G; Aron M; Gill IS; Duddalwar VA
    Urology; 2018 Apr; 114():121-127. PubMed ID: 29305199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement patterns of renal masses during multiphase helical CT acquisitions.
    Garant M; Bonaldi VM; Taourel P; Pinsky MF; Bret PM
    Abdom Imaging; 1998; 23(4):431-6. PubMed ID: 9663282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches.
    Zokalj I; Marotti M; Kolarić B
    Int Urol Nephrol; 2014 Jun; 46(6):1089-100. PubMed ID: 24381132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: a central scar-matched retrospective study.
    Li X; Nie P; Zhang J; Hou F; Ma Q; Cui J
    Acta Radiol; 2022 Feb; 63(2):253-260. PubMed ID: 33497276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative differentiation of minimal-fat angiomyolipomas from renal cell carcinomas using grating-based x-ray phase-contrast computed tomography: An ex vivo study.
    Birnbacher L; Braunagel M; Willner M; Marschner M; De Marco F; Viermetz M; Auweter S; Notohamiprodjo S; Hellbach K; Notohamiprodjo M; Staehler M; Pfeiffer D; Reiser MF; Pfeiffer F; Herzen J
    PLoS One; 2023; 18(4):e0279323. PubMed ID: 37058505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.